drugset / Trial / NCT00047203

Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00047203

Phase 2 Completed 35 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Phase II trial to study the effectiveness of flavopiridol in treating patients who have relapsed or refractory multiple myeloma

Timeline

Start
2002-09
Primary completion
2006-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject alvocidib Small molecule Intravenous